CAR T-cell therapy remains the ‘hottest story’ in lupus, autoimmune disease

DESTIN, Fla. — Positive results for chimeric antigen receptor T-cell therapy in systemic sclerosis and myositis have added fuel to the fire of recent landmark data in lupus, said a speaker at the Congress of Clinical Rheumatology East.
“The hottest story in lupus and perhaps in autoimmune diseases in general are CAR T cells,” Ronald van Vollenhoven, MD, PhD, chair of the department of rheumatology and clinical immunology at the Amsterdam Medical Center, and director of the Amsterdam Rheumatology Center Academic Medical Center, told attendees. “It is an extremely complex

Back to news